Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating

Kentaro Nagaoka1, Katsunori Yanagihara, Yoshitomo Morinaga

  • 1Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Infection and Immunity
|January 31, 2014
PubMed

Insights

Prevotella intermedia exacerbates pneumococcal pneumonia by increasing bacterial spread and inflammation. This oral bacterium enhances pneumococcus adhesion to lung cells, leading to more severe respiratory infections.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonology

Background:

  • Streptococcus pneumoniae is a primary cause of pneumonia globally.
  • The link between oral bacteria and pneumococcal infection severity remains unclear.
  • Oral hygiene is a potential risk factor for pneumonia development.

Purpose of the Study:

  • To investigate the synergistic effects of Prevotella intermedia on pneumococcal pneumonia.
  • To determine if P. intermedia enhances pneumococcal adhesion to lung cells.
  • To analyze the impact of P. intermedia on inflammatory responses and survival rates.

Main Methods:

  • Mice were inoculated with S. pneumoniae and P. intermedia supernatant (PiSup).
  • Pneumococcal adhesion to A549 cells was assessed in vitro.
  • Platelet-activating factor receptor (PAFR) transcript levels were analyzed using quantitative real-time PCR.
  • Inflammatory cytokine levels and survival rates were measured.

Main Results:

  • Mice co-infected with S. pneumoniae and PiSup showed decreased survival and increased bacterial load in lungs, spleen, and blood.
  • PiSup significantly increased pneumococcal adhesion to A549 cells and PAFR transcript levels.
  • Elevated levels of inflammatory cytokines (MIP-2, TNF-alpha) were observed in bronchoalveolar lavage fluid.
  • Supernatants from Porphyromonas gingivalis and Fusobacterium nucleatum did not produce similar effects.

Conclusions:

  • Prevotella intermedia supernatant potentiates severe, bacteremic pneumococcal pneumonia.
  • P. intermedia enhances pneumococcal adhesion to lower airway cells via PAFR.
  • This interaction highlights a significant risk factor for severe pneumococcal respiratory infections.